Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Trading Statement

6 Oct 2009 07:00

RNS Number : 2761A
Byotrol PLC
06 October 2009
 



Byotrol plc (the "Company")

UPDATE ON TRADING

The Board is pleased to announce a further positive update on trading in relation to the six months ended 30 September 2009.

As highlighted in the announcement dated 17 September, the first half of the current financial year has been characterised by a significant increase in orders for Byotrol products. This trend has continued through to the end of the half year and as a result the Board is pleased to report that product sales for the six months ended 30 September 2009 will be in the order of £1.5m (£0.2m for the comparative period). There was an additional one off license payment of £450k bringing total revenues to approximately £1.9m as compared to £0.4m for the same period last year.

The Board believes certain key factors have underpinned the interest in, and orders for, Byotrol products. One has been the increased public and businesss awareness of the products following the success of the Manchester Royal Infirmary trial which demonstrated that Byotrol outperformed the NHS's gold standard cleaning regime. Another is the increased public awareness of the requirement for better personal hygiene stemming, in part, from the threat of swine flu. The third key factor is the continued growth in the recognition of Byotrol's superiority to other products in that it continues to work even when dry.

Highlights of the Company's activities during the period include the receipt of significant orders for supply to major retailers for the protection of their staff. The Company has also despatched material orders to Arco, one of the UK's leading Health and Safety product suppliers. 

"I am very pleased with the sales performance for the first half" said CEO David McRobbie. "The unprecedented increase in orders gave rise to some temporary issues in relation to sourcing bottles and caps and the Company turned to suppliers in both Europe and North America. This has had an unavoidable short term impact on margins. We have, however, addressed the bottles supply issue via a manufacturing arrangement with a major bottle supplier. Accordingly, the Board expect that margins should improve in the second half of the current financial year."

The eight fold increase in activity levels has also been reflected in an increased working capital requirement and the Board has taken steps to address this. As at 30 September, the Company had cash of £1.6m.

The Company has a good forward order book for the third quarter of the financial year but the nature of the business means that, at the current time, there is more limited visibility for the final quarter. As a consequence, the Board's current view is that the results for the financial year will be in line with market expectations.

The Board will provide a further update at the time of the announcement of the interim results in mid November.

Enquiries:

 

Byotrol plc
 
 
Richard Bell, Finance Director
 
Tel 0161 277 9518
Charles Stanley Securities
Nominated Adviser & Broker
 
 
Philip Davies / Carl Holmes
Tel 020 7149 6000

 

6 October 2009 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUGAGUUPBPUA
Date   Source Headline
1st Nov 202111:36 amRNSTotal Voting Rights
1st Nov 202111:20 amRNSHolding(s) in Company
28th Oct 202111:40 amRNSExercise of Options & Total Voting Rights
20th Oct 20214:46 pmRNSResult of AGM
1st Oct 20217:00 amRNSSale of Byotrol24 in the Americas
27th Sep 20214:36 pmRNSPosting of Annual Report & Accounts/Notice of AGM
1st Sep 20217:00 amRNSInvestor Presentation
20th Aug 202110:01 amRNSHolding(s) in Company
19th Aug 20217:00 amRNSFinal Results
27th Jul 20217:00 amRNSNotice of Results
21st Jun 20217:00 amRNSAlcohol-free Hand Sanitisers Backed by TIGGR
28th Apr 20219:47 amRNSExercise of Options & Total Voting Rights
27th Apr 20217:00 amRNSHolding(s) in Company
22nd Apr 20212:05 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:00 pmRNSPrice Monitoring Extension
22nd Apr 20217:00 amRNSTrading Update
16th Apr 20214:40 pmRNSHolding(s) in Company
26th Feb 20217:00 amRNSTest Protocol for Testing Anti-Viral Efficacy
21st Jan 202110:30 amRNSExercise of Options & Total Voting Rights
8th Jan 20219:36 amRNSCapital reduction
21st Dec 20208:26 amRNSHolding(s) in Company
7th Dec 20207:00 amRNSInterim Results
13th Nov 202011:30 amRNSResult of AGM
13th Nov 20207:00 amRNSAGM Statement
6th Nov 202011:27 amRNSAnnual General Meeting – update on arrangements
20th Oct 20201:42 pmRNSPosting of circular & notice of AGM
14th Oct 20204:30 pmRNSExercise of Options & Total Voting Rights
13th Oct 202011:09 amRNSPUBLICATION OF AUDITED RESULTS
25th Sep 20207:00 amRNSDirector Dealing
25th Sep 20207:00 amRNSInvestor Presentation
24th Sep 20207:00 amRNSPreliminary Results
7th Sep 20207:00 amRNSGrant Award
27th Aug 20208:07 amRNSHolding(s) in Company
20th Aug 20208:10 amRNSHolding(s) in Company
18th Aug 20205:01 pmRNSHolding(s) in Company
18th Aug 20204:42 pmRNSSecond Price Monitoring Extn
18th Aug 20204:36 pmRNSPrice Monitoring Extension
17th Aug 20209:05 amRNSSecond Price Monitoring Extn
17th Aug 20209:00 amRNSPrice Monitoring Extension
3rd Aug 20207:00 amRNSTrading Update
16th Jul 20202:40 pmRNSHolding(s) in Company
3rd Jul 20207:00 amRNSExercise of Options and Total Voting Rights
29th Jun 20204:29 pmRNSHolding(s) in Company
19th May 202012:08 pmRNSHolding(s) in Company
14th May 20207:00 amRNSLicense Agreements and Update on Trading
27th Apr 20207:30 amRNSTrading Update
22nd Apr 20204:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20204:36 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSHolding(s) in Company
6th Apr 202011:26 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.